THE INQUIRY: Teva Pharmaceutical Industries Ltd. says the Securities and Exchange Commission is investigating possible bribery by Teva's business in Latin America. Teva said Thursday that it received a subpoena from the SEC in July.

THE LAW: The SEC is looking into Teva's compliance with the Foreign Corrupt Practices Act, which bans bribery to officials of foreign governments. The Israeli company said the SEC investigation is in its early stages and that it is also conducting its own investigation.

WHO: Teva is the largest generic drug company in the world. Its revenue topped $18 billion in 2011.